Updates on CAR-T in Multiple Myeloma

 

SOHO 2022 Tenth Annual Meeting
N

SOHO 2022: CAR T-Cell in MM - When To Use Now, Where Are We Going?

By SOHO 2022 Tenth Annual Meeting FEATURING Noopur S. Raje
By SOHO 2022 Tenth Annual Meeting FEATURING Noopur S. Raje
97 views
October 14, 2022
0 Comments
Login to view comments. Click here to Login
Updates on CAR-T in Multiple Myeloma
06:12
Maximilian Merz

Patient Selection for Ciltacabtagene Autoleucel Therapy in R/R MM

11:43
UCSF School of Medicine

CARTITUDE-1: 2 Years Post-LPI Update on the Phase 1b/2 Study of Cilt…

Feat. T. Martin
15:29
SOHO Brazil 2022

SOHO Brazil 2022 on CAR-T in Refractory MM: When Is the Precise Mome…

Feat. M. Bishop, P. Scheinberg
21:16
UChicago Medicine

Myeloma 2022: Challenges and Path Forward

Feat. A. Jakubowiak
04:08
GRACE

CAR T-Cell Therapy Side Effects for Blood Cancers

Feat. A. Goodman
21:38
Rahul Banerjee

CAR-T Therapy in Myeloma: What's Here and What's Coming So…

12:11
SOHO 2022 Tenth Annual Meeting

SOHO 2022 DEBATE: Bispecific Antibodies vs. CAR-T for R/R MM - Pro C…

Feat. T. Martin
14:22
SOHO 2022 Tenth Annual Meeting

SOHO 2022: CAR T-Cell in MM - When To Use Now, Where Are We Going?

Feat. N. S. Raje
19:05
UChicago Medicine

Identifying and Managing Major Toxicities of CAR-T Therapy in Multip…

Feat. S. Kosuri
05:32
Enrique Ocio

Triple Refractory MM Patients: Learnings From the MAMMOTH and the Lo…

08:13
Shaji Kumar

CAR-T in MM: Benefits of a Treatment-Free Interval

06:58
Saurabh Chhabra

Summary of the MAMMOTH Trial in R/R Myeloma

14:41
Zhubin Gahvari

MAMMOTH Trial: Myeloma Outcomes Post Anti-CD38 MoAbs

05:05
ASH 2022 Conference Coverage

ASH 2022 Outcomes of Penta-Refractory MM Patients Based on Access to…

Feat. S. Atrash
14:03
ASH 2022 Conference Coverage

ASH 2022 Neurotoxicity With Motor Symptoms After BCMA-Directed CAR-T…

Feat. S. Parekh
31:51
Indy Hematology Review

Treating Multiple Myeloma: The Cure Is Within Reach - Goals of Curre…

Feat. K. Anderson